Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q80Z64 (NANOG_MOUSE)

Last modified January 19, 2010. Version 60. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Homeobox protein NANOG
Alternative name(s):
    Homeobox transcription factor Nanog
    Early embryo specific expression NK-type homeobox protein
    ES cell-associated protein 4
Gene names
Name: Nanog
Synonyms: Ecat4, Enk
OrganismMus musculus (Mouse)
Taxonomic identifier10090 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMus

Protein attributes

Sequence length305 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Transcription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal. Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. Acts as a transcriptional activator or repressor. Binds optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-[CG][GA][CG]C[GC]ATTAN[GC]-3'. When overexpressed, promotes cells to enter into S phase and proliferation By similarity. Ref.1 Ref.2 Ref.6 Ref.8 Ref.13 Ref.14 Ref.15

Subunit structure

Interacts with SMAD1 and SALL4. Ref.15 Ref.12 Ref.16

Subcellular location

Nucleus Ref.9.

Tissue specificity

Not expressed in oocytes and spermatogonia (at protein level). Not expressed in many somatic organs, ovary, testis, fibroblast and hematopoietic cell lines. Ref.1 Ref.2 Ref.4 Ref.7

Developmental stage

Expressed in the central portion of the morula, the inner cell mass (ICM) of the blastocyst, in embryonic stem (ES) and embryonic germ (EG) cells, in the epiblast between 6.5 and 7.5 dpc, in primordial germ cells (PGCs) between 7.75 and 12.5 dpc (at protein level). The expression in PGCs decreases in female germ cells that entered meiosis at 13.5 dpc and in male germ cells that entered mitotic arrest at 14.5 dpc (at protein level). Not expressed in unfertilized eggs or 2- or 8-cell-stage embryos (at protein level). Expressed in the central portion of the morula, the inner cell mass (ICM) of the blastocyst, in ES and EG cells, in the epiblast at 6 dpc and in PGCs of genital ridges between 11.5 and 12.5 dpc. Expression decreases with ES differentiation. Ref.1 Ref.2 Ref.9 Ref.4 Ref.7 Ref.3

Induction

By the transcription factor POU5F1 in ES cells that acts as a direct biphasic regulator: a steady-state concentration of POU5F1 up-regulated its expression, while an elevated concentration of POU5F1 down-regulated its expression. Up-regulated by the transcription factor FOXD3. Up-regulated in ES cells by transcription factors T (Brachyury) and STAT3. Down-regulated by p53 in response to DNA damage induced by ultraviolet light (UV) or doxorubicin. Down-regulated upon ES differentiation. Ref.14 Ref.15 Ref.10 Ref.11

Miscellaneous

Knockout mice resulted in loss of pluripotency in both ICM and ES cells and differentiated into extraembryonic (parietal and visceral) endoderm lineage.

'Nanog' is derived from 'Tir nan Og' the mythologic Celtic land of the ever young.

Sequence similarities

Belongs to the Nanog homeobox family.

Contains 1 homeobox DNA-binding domain.

Ontologies

Keywords
   Biological processTranscription
Transcription regulation
   Cellular componentNucleus
   Coding sequence diversityAlternative splicing
   DomainHomeobox
Repeat
   LigandDNA-binding
   Molecular functionActivator
Developmental protein
Repressor
   Technical term3D-structure
Direct protein sequencing
Gene Ontology (GO)
   Biological processembryonic pattern specification Ref.4

Inferred from expression pattern. Source: HGNC

gonad development Ref.4

Inferred from expression pattern. Source: HGNC

mesodermal cell fate commitment Ref.15

Inferred from genetic interaction. Source: MGI

negative regulation of BMP signaling pathway Ref.15

Inferred from direct assay. Source: MGI

negative regulation of endodermal cell fate specification

Traceable author statement. Source: HGNC

negative regulation of transcription from RNA polymerase II promoter Ref.15

Inferred from genetic interaction. Source: MGI

positive regulation of cell proliferation

Inferred from direct assay. Source: MGI

positive regulation of mitotic cell cycle

Inferred from direct assay. Source: MGI

response to retinoic acid

Inferred from direct assay. Source: MGI

stem cell division Ref.2

Inferred from direct assay. Source: MGI

stem cell maintenance Ref.1 Ref.15

Inferred from direct assay. Source: MGI

transcription

Inferred from electronic annotation. Source: UniProtKB-KW

   Cellular componentnucleus Ref.9

Inferred from direct assay. Source: MGI

   Molecular functionprotein binding

Inferred from physical interaction. Source: IntAct

sequence-specific DNA binding

Inferred from direct assay. Source: MGI

transcription factor activity

Inferred from electronic annotation. Source: InterPro

Complete GO annotation...

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q80Z64-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q80Z64-2)

Also known as: Nanog1a; Nanog1b;

The sequence of this isoform differs from the canonical sequence as follows:
     1-25: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 305305Homeobox protein NANOG
PRO_0000261419

Regions

Repeat198 – 20251
Repeat203 – 20752
Repeat208 – 21253
Repeat213 – 21754
Repeat218 – 22255
Repeat223 – 22756
Repeat228 – 23257
Repeat233 – 23758
Repeat238 – 24259
Repeat243 – 247510
DNA binding96 – 15560Homeobox Ref.1 Ref.8 Ref.12
Region96 – 15560Sufficient for interaction with SALL4
Region198 – 2475010 X repeats starting with a Trp in each unit
Region198 – 24750Sufficient for transactivation activity
Region248 – 30558Sufficient for strong transactivation activity
Compositional bias198 – 24346Trp-rich

Natural variations

Alternative sequence1 – 2525Missing in isoform 2.
VSP_021689

Experimental info

Mutagenesis1121K → E: Increases affinity for DNA and protein stability; when associated with R-147. Ref.16
Mutagenesis1261M → R: Increases affinity for DNA; when associated with E-137. Ref.16
Mutagenesis1371Y → E: Increases affinity for DNA; when associated with R-126. Ref.16
Mutagenesis1381K → E: Reduced affinity for DNA. Ref.16
Mutagenesis1421T → I: Slightly reduced affinity for DNA. Ref.16
Mutagenesis1461N → E: Strongly reduced affinity for DNA. Ref.16
Mutagenesis1471Q → R: Increases affinity for DNA and protein stability; when associated with E-112. Ref.16
Sequence conflict1491M → V in BAC76998. Ref.1

Secondary structure

......... 305
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified June 1, 2003. Version 1.
Checksum: 4EF96408B767C79F

FASTA30534,240
        10         20         30         40         50         60 
MSVGLPGPHS LPSSEEASNS GNASSMPAVF HPENYSCLQG SATEMLCTEA ASPRPSSEDL 

        70         80         90        100        110        120 
PLQGSPDSST SPKQKLSSPE ADKGPEEEEN KVLARKQKMR TVFSQAQLCA LKDRFQKQKY 

       130        140        150        160        170        180 
LSLQQMQELS SILNLSYKQV KTWFQNQRMK CKRWQKNQWL KTSNGLIQKG SAPVEYPSIH 

       190        200        210        220        230        240 
CSYPQGYLVN ASGSLSMWGS QTWTNPTWSS QTWTNPTWNN QTWTNPTWSS QAWTAQSWNG 

       250        260        270        280        290        300 
QPWNAAPLHN FGEDFLQPYV QLQQNFSASD LEVNLEATRE SHAHFSTPQA LELFLNYSVT 


PPGEI 

« Hide

Isoform 2 (Nanog1a) (Nanog1b).

Checksum: 090B8AC6C26A37C6
Show »

FASTA28031,859

References

« Hide 'large scale' references
[1]"The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells."
Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S.
Cell 113:631-642(2003) [PubMed: 12787504] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DNA-BINDING, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY.
[2]"Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells."
Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A.
Cell 113:643-655(2003) [PubMed: 12787505] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DEVELOPMENTAL STAGE, TISSUE SPECIFICITY.
Strain: 129/Ola.
Tissue: Embryonic stem cell.
[3]"A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells."
Wang S.-H., Tsai M.-S., Chiang M.-F., Li H.
Gene Expr. Patterns 3:99-103(2003) [PubMed: 12609610] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DEVELOPMENTAL STAGE.
Strain: FVB.
Tissue: Embryonic stem cell.
[4]"Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human."
Hart A.H., Hartley L., Ibrahim M., Robb L.
Dev. Dyn. 230:187-198(2004) [PubMed: 15108323] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), DEVELOPMENTAL STAGE, TISSUE SPECIFICITY.
Strain: C57BL/6.
[5]"The transcriptional landscape of the mammalian genome."
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. expand/collapse author list , Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.
Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Strain: C57BL/6J.
Tissue: Embryonic stem cell.
[6]"Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog."
Pan G.J., Pei D.Q.
Cell Res. 13:499-502(2003) [PubMed: 14728807] [Abstract]
Cited for: FUNCTION.
[7]"Nanog expression in mouse germ cell development."
Yamaguchi S., Kimura H., Tada M., Nakatsuji N., Tada T.
Gene Expr. Patterns 5:639-646(2005) [PubMed: 15939376] [Abstract]
Cited for: DEVELOPMENTAL STAGE, TISSUE SPECIFICITY.
[8]"The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus."
Pan G., Pei D.
J. Biol. Chem. 280:1401-1407(2005) [PubMed: 15502159] [Abstract]
Cited for: FUNCTION, DNA-BINDING.
[9]"Pluripotential competence of cells associated with Nanog activity."
Hatano S.Y., Tada M., Kimura H., Yamaguchi S., Kono T., Nakano T., Suemori H., Nakatsuji N., Tada T.
Mech. Dev. 122:67-79(2005) [PubMed: 15582778] [Abstract]
Cited for: SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE.
[10]"p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression."
Lin T., Chao C., Saito S., Mazur S.J., Murphy M.E., Appella E., Xu Y.
Nat. Cell Biol. 7:165-171(2005) [PubMed: 15619621] [Abstract]
Cited for: INDUCTION.
[11]"A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal."
Pan G., Li J., Zhou Y., Zheng H., Pei D.
FASEB J. 20:1730-1732(2006) [PubMed: 16790525] [Abstract]
Cited for: INDUCTION.
[12]"Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells."
Wu Q., Chen X., Zhang J., Loh Y.-H., Low T.-Y., Zhang W., Zhang W., Sze S.-K., Lim B., Ng H.-H.
J. Biol. Chem. 281:24090-24094(2006) [PubMed: 16840789] [Abstract]
Cited for: INTERACTION WITH SALL4, DNA-BINDING.
[13]"Nanog promotes transfer of pluripotency after cell fusion."
Silva J., Chambers I., Pollard S., Smith A.
Nature 441:997-1001(2006) [PubMed: 16791199] [Abstract]
Cited for: FUNCTION.
[14]"The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells."
Loh Y.-H., Wu Q., Chew J.-L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., Wong K.-Y., Sung K.W., Lee C.W., Zhao X.-D., Chiu K.-P., Lipovich L., Kuznetsov V.A., Robson P. expand/collapse author list , Stanton L.W., Wei C.-L., Ruan Y., Lim B., Ng H.-H.
Nat. Genet. 38:431-440(2006) [PubMed: 16518401] [Abstract]
Cited for: FUNCTION, INDUCTION.
[15]"Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells."
Suzuki A., Raya A., Kawakami Y., Morita M., Matsui T., Nakashima K., Gage F.H., Rodriguez-Esteban C., Izpisua Belmonte J.C.
Proc. Natl. Acad. Sci. U.S.A. 103:10294-10299(2006) [PubMed: 16801560] [Abstract]
Cited for: FUNCTION, INTERACTION WITH SMAD1, INDUCTION.
[16]"Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog."
Jauch R., Ng C.K.L., Saikatendu K.S., Stevens R.C., Kolatkar P.R.
J. Mol. Biol. 376:758-770(2008) [PubMed: 18177668] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 96-155, INTERACTION WITH DNA, PARTIAL PROTEIN SEQUENCE, MUTAGENESIS OF LYS-112; MET-126; TYR-137; LYS-138; THR-142; ASN-146 AND GLN-147.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AB093574 mRNA. Translation: BAC76998.1.
AY278951 mRNA. Translation: AAP92157.1.
AF507043 mRNA. Translation: AAO67362.1.
AY455282 mRNA. Translation: AAS57554.1.
AY455285 mRNA. Translation: AAS57556.1.
AK010332 mRNA. Translation: BAE43219.1.
IPIIPI00109731.
IPI00807949.
RefSeqNP_082292.1.
UniGeneMm.478080
Mm.6047

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
2VI6X-ray2.60A/B/C/D/E/F/G/H96-155[»]
ModBaseSearch...

Protein-protein interaction databases

DIPDIP-29925N.
DIP-29932N.
IntActQ80Z64. 17 interactions.
STRINGQ80Z64.

Proteomic databases

PRIDEQ80Z64.

Genome annotation databases

EnsemblENSMUST00000012540; ENSMUSP00000012540; ENSMUSG00000012396; Mus musculus. [Genome view]
GeneID71950.
KEGGmmu:71950.
UCSCuc009dpo.1. mouse.

Organism-specific databases

CTD71950.
MGIMGI:1919200. Nanog.

Phylogenomic databases

HOGENOMHBG126619.
HOVERGENQ80Z64.
InParanoidQ80Z64.
OMAHDSSTSP.
PhylomeDBQ80Z64.

Gene expression databases

ArrayExpressQ80Z64.
BgeeQ80Z64.
GenevestigatorQ80Z64.
GermOnlineENSMUSG00000012396. Mus musculus.

Family and domain databases

InterProIPR001356. Homeobox.
IPR017970. Homeobox_CS.
IPR009057. Homeodomain-like.
IPR012287. Homeodomain-rel.
[Graphical view]
Gene3DG3DSA:1.10.10.60. Homeodomain-rel. 1 hit.
PfamPF00046. Homeobox. 1 hit.
[Graphical view]
SMARTSM00389. HOX. 1 hit.
[Graphical view]
PROSITEPS00027. HOMEOBOX_1. 1 hit.
PS50071. HOMEOBOX_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio335028.
SOURCESearch...

Entry information

Entry nameNANOG_MOUSE
AccessionPrimary (citable) accession number: Q80Z64
Secondary accession number(s): Q6SMR1, Q7TN85
Entry history
Integrated into UniProtKB/Swiss-Prot: November 28, 2006
Last sequence update: June 1, 2003
Last modified: January 19, 2010
This is version 60 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

MGD cross-references

Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents